BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16374400)

  • 1. Statins for high-risk patients without heart disease or high cholesterol.
    Med Lett Drugs Ther; 2006 Jan; 48(1225):1-3. PubMed ID: 16374400
    [No Abstract]   [Full Text] [Related]  

  • 2. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins.
    Prescrire Int; 2003 Aug; 12(66):143-8. PubMed ID: 12908497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
    März W
    MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
    [No Abstract]   [Full Text] [Related]  

  • 6. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 7. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 9. Stroke prevention, blood cholesterol and statins.
    Amarenco P; Lavallée PC; Labreuche J; Touboul PJ
    Acta Neurol Taiwan; 2005 Sep; 14(3):96-112. PubMed ID: 16252611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Knopp RH; Paramsothy P
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):136-7. PubMed ID: 16932272
    [No Abstract]   [Full Text] [Related]  

  • 11. A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels.
    Maclaine GD; Patel H
    Int J Clin Pract; 2001 May; 55(4):243-9. PubMed ID: 11406909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins utilisation pattern: a retrospective evaluation in a tertiary care hospital in Thailand.
    Chaiyakunapruk N; Asuphol O; Dhippayom T; Poowaruttanawiwit P; Jeanpeerapong N
    Int J Pharm Pract; 2011 Apr; 19(2):129-35. PubMed ID: 21385244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins: not just for the young or the faint of heart.
    Coull BM; Johnston SC
    Neurology; 2009 Feb; 72(8):684-5. PubMed ID: 19237695
    [No Abstract]   [Full Text] [Related]  

  • 16. Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.
    Ballantyne CM; Bertolami M; Hernandez Garcia HR; Nul D; Stein EA; Theroux P; Weiss R; Cain VA; Raichlen JS
    Am Heart J; 2006 May; 151(5):975.e1-9. PubMed ID: 16644314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective use of statins to prevent coronary heart disease.
    Crouch MA
    Am Fam Physician; 2001 Jan; 63(2):309-20, 323-4. PubMed ID: 11201696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of atorvastatin and simvastatin as monotherapy for mixed hyperlipidaemia in Type 2 diabetic patients.
    Chan WB; Ko GT; Yeung VT; Osaki R; Ma RC; So WY; Chow CC
    Diabetes Res Clin Pract; 2004 Oct; 66(1):97-9. PubMed ID: 15364167
    [No Abstract]   [Full Text] [Related]  

  • 20. Statins: much more than just a lipid-lowering therapy.
    Raja SG; Dreyfus GD
    Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.